Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection.
Al-Obaidi MM, Gungor AB, Nematollahi S, Zangeneh TT, Bedrick EJ, Johnson KM, Low-Adegbija NE, Alam R, Rangan P, William Heise C, Ariyamuthu VK, Shetty A, Qannus AA, Murugapandian S, Ayvaci MMS, Anand PM, Tanriover B.
Al-Obaidi MM, et al. Among authors: zangeneh tt.
Open Forum Infect Dis. 2022 Apr 12;9(7):ofac186. doi: 10.1093/ofid/ofac186. eCollection 2022 Jul.
Open Forum Infect Dis. 2022.
PMID: 35791354
Free PMC article.